FDA

The FDA granted accelerated approval to atacicept (Trutakna) for reducing proteinuria in adults with primary IgA nephropathy at risk of disease progression. Approval was supported by data from the ORIGIN 3 trial for the once-weekly self-administered drug.

The FDA approved Trutakna, a new treatment for IgA nephropathy, a chronic autoimmune kidney disease, developed by Vera Therapeutics. Vera CEO Marshall Fordyce expressed excitement about bringing the drug to patients.

Vertex Pharmaceuticals acquired Crinetics Pharmaceuticals for $10 billion, gaining access to Palsonify, a drug for acromegaly, and other drug candidates. The deal marks Vertex's largest acquisition as it expands beyond its cystic fibrosis portfolio.

Novartis acquired Myricx Bio for $1.1 billion to advance its antibody-drug conjugate (ADC) pipeline with a novel NMTi payload. Congressional Republicans passed a bill funding the FDA, including a report urging the agency to implement requirements for diversifying clinical trials.

A voluntary recall has been issued for Oribe Serene Scalp Densifying Shampoo due to the detection of Pluralibacter gergoviae bacteria, which can cause infections. Kao USA advises stopping use of affected lots manufactured between Feb. 21, 2026, and Feb. 26, 2026.

Some canned Pedigree High Protein Chopped Chicken and Duck Flavor dog food is being recalled due to possible metal and plastic contamination. The FDA states the product was fraudulently diverted in the U.S., but no pet illnesses have been reported. Affected cans have lot codes 613C3KKCFC and 613C1KKCFC.

Some canned Pedigree High Protein Chopped Chicken and Duck Flavor dog food is being recalled due to possible metal and plastic contamination. The FDA states the product was fraudulently diverted in the U.S., but no illnesses have been reported. Consumers are advised not to feed the affected batches to pets and to contact Pedigree for a replacement.

Some canned Pedigree dog food is being voluntarily recalled due to potential metal and plastic contamination. The affected product is High Protein Chopped Chicken and Duck Flavor with specific lot codes, as reported by the FDA. No illnesses have been reported, and consumers are advised not to feed the recalled product to pets.

The FDA ruled that ZYN nicotine pouches can be advertised as a less-harmful option for adult smokers compared to cigarettes. However, the article emphasizes that quitting all tobacco and nicotine products remains the best course of action.

The FDA authorized 20 ZYN nicotine pouches to carry a modified risk claim. This allows the product to be marketed with a label indicating reduced health risks compared to traditional tobacco products.

The article discusses the challenge of living past 115 years despite more people reaching 100. The Limit host Daniel T. Allen investigated through interviews and tests, while Business Insider explored potential lifespan extensions like FDA-approved drugs and Bryan Johnson's 'Don't Die' protocol.

Utz Quality Foods has elevated its ongoing potato chips recall to the FDA’s highest risk level due to Salmonella contamination in a seasoning ingredient. The recall affects popular potato chip brands and is categorized as the most severe by the FDA.

Utz potato chips issued a highest-level FDA recall due to salmonella concerns. The recall includes specific products: Dirty sour cream and onion chips and Zapp's salt and vinegar chips.

A potato chip recall has been upgraded to the FDA's highest risk level. Consumers are instructed to discard affected products and seek refunds from Utz.

Roche's drug establishes a new standard for treating KRAS-driven lung cancer. The article is part of a biotech newsletter discussing recent developments in the sector, including FDA regulatory updates and political changes affecting biopharma policy.

A potato chip recall has been elevated to the FDA's highest risk level. Consumers are advised to discard affected products and contact Utz for refunds.

A potato chip recall has been elevated to the FDA's highest risk level. Consumers are advised to discard affected products and contact Utz for refunds.

The FDA has upgraded a recall of several popular potato chip brands to its most serious level due to salmonella contamination risk, affecting an estimated 650,000 bags. Manufacturer Utz issued a voluntary recall for Zapp’s and Dirty potato chips, citing possible salmonella in dry milk powder from a third-party supplier.

FDA career scientists have determined there is insufficient evidence to support peptides under consideration for production by compounding, countering HHS Secretary Robert F. Kennedy Jr.'s efforts to expand access to these substances.

Alibaba will pay $600 million to the U.S. government to settle allegations that its platforms allowed the sale and import of illegal pharmaceuticals, controlled substances, and related equipment between 2016 and 2024. The settlement resolves claims that Alibaba’s U.S. payment processor failed to prevent unlawful transactions, leading to a non-prosecution agreement with the Justice Department.

The FDA approved Orca-T (Tregzi), an allogeneic regulatory T cell-based immunotherapy product combined with hematopoietic stem and progenitor cells and T cells, to prevent graft-versus-host disease (GVHD) in stem cell transplants for hematologic cancers.

The FDA upgraded a potato chip recall to the highest risk level due to salmonella concerns. Utz Quality Foods initially recalled the chips in May.

The FDA upgraded a potato chip recall to the highest risk level due to salmonella concerns. The chips were initially recalled in May by Utz Quality Foods.

Utz Quality Foods upgraded a potato chip recall to the highest FDA risk level due to salmonella concerns. The initial recall was issued in May.

The FDA has upgraded the risk level of a potato chip recall to the highest level due to salmonella concerns. The initial recall was issued in May by Utz Quality Foods.

Congo's Ebola outbreak has confirmed 1,274 cases and 360 deaths, per the CDC. The FDA has rejected a kidney disease drug. Ugandan officials also reported an outbreak, though details are incomplete.

The FDA has approved Zyn to market its nicotine pouches as safer than cigarettes. The article also mentions STAT’s free health newsletter and a temporary substitution in its editorial team.

The FDA approved Orca Bio's T cell therapy, Tregzi, which reduces immune reaction risks for blood cancer patients undergoing stem cell transplants. The therapy offers a curative alternative to traditional transplants that carry high risks of chronic graft-versus-host disease.

Galderma's stock declined following the FDA's rejection of Relfydess, a Botox competitor. The decision negatively impacted the company's market performance.

Kelly Rosenthal's death from nitrous oxide addiction led to Tennessee legislation banning its sale at vape shops. A WSMV4 investigation revealed easy access to nitrous oxide at vape shops, prompting bipartisan support for the Nitrous Oxide Abuse Prevention and Retail Sales Prohibition Act.

FDA scientists have raised concerns about the lack of evidence for the efficacy and safety of peptides, which are supported by RFK Jr. An FDA panel will consider easing access to peptides later this month despite these concerns.

The FDA conducted a survey indicating that ZYN nicotine pouches are the most popular among middle and high school students who use such products. The FDA is evaluating whether ZYN nicotine pouches are safer than smoking.

Nearly 1 million bottles of a heart failure medication are being recalled nationwide due to potential contamination with a foreign substance, as reported in an FDA recall alert.

The FDA has selected Eli Lilly and Regeneron for its PreCheck program, which aims to expedite domestic drug factory reviews by assessing facilities during construction. The program could save participating companies up to 14 months in review time.

The FDA has expanded a cheese recall due to possible listeria contamination. Consumers are advised to return the recalled products for a full refund.

The FDA will convene a panel to review the safety of popular peptide injections, with participants including doctors and pharmacists financially tied to the peptide industry. The meeting, part of efforts to reshape health policy under Robert F. Kennedy Jr., will assess peptides like BPC-157 and TB-500, which the FDA has previously warned are unapproved and risky.

The FDA's upcoming panel to review controversial peptide drugs includes health professionals with financial ties to the industry, including clinics and pharmacies promoting unproven peptides. The meeting follows concerns about the safety and regulatory status of substances like BPC-157 and TB-500, which are marketed for wellness purposes but lack scientific validation. Health Secretary Robert F. Kennedy Jr. has publicly supported these peptides.

The FDA has launched a pilot program with Eli Lilly and Regeneron to accelerate the development and approval of U.S. drug manufacturing facilities by engaging companies during design and construction phases. The initiative aims to reduce delays, improve compliance, and strengthen the domestic pharmaceutical supply chain to reduce reliance on overseas production.

Eli Lilly and Regeneron are among the first seven companies selected by the FDA for its PreCheck Pilot Program, an initiative aimed at accelerating the review of new manufacturing facilities. The program was reported by CNBC.

The FDA expanded the indications for risankizumab (Skyrizi) in plaque psoriasis and psoriatic arthritis to include treatment of children 6 years and older. AbbVie announced this update, noting risankizumab is an interleukin (IL)-23 antagonist.